Bromine → 6-(5-amino-[1,2,4]thiadiazol-3-ylthiomethyl)-3-tert-butoxycarbonyl-7-chloro-2,3,4,5-tetrahydro-1H-benzo[d]azepine

HRID 1670570노트

반응식

HRID 1670570 반응식
Cl.[C:2]([O:6][C:7]([N:9]1[CH2:15][CH2:14][C:13]2[C:16]([CH2:21][S:22][C:23](=[NH:25])[NH2:24])=[C:17]([Cl:20])[CH:18]=[CH:19][C:12]=2[CH2:11][CH2:10]1)=[O:8])([CH3:5])([CH3:4])[CH3:3].C[O-].[Na+].[C:29]([S-:31])#[N:30].[K+].BrBr>CO>[NH2:30][C:29]1[S:31][N:24]=[C:23]([S:22][CH2:21][C:16]2[C:13]3[CH2:14][CH2:15][N:9]([C:7]([O:6][C:2]([CH3:5])([CH3:3])[CH3:4])=[O:8])[CH2:10][CH2:11][C:12]=3[CH:19]=[CH:18][C:17]=2[Cl:20])[N:25]=1

참가 물질

6

반응물 4

HCID 24408BromineHCID 516872Potassium thiocyanateHCID 10942334Sodium MethoxideHCID 673354473-tert-Butoxycarbonyl-6-carbamimidoylthiomethyl-7-chloro-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride

생성물 1

HCID 673359726-(5-amino-[1,2,4]thiadiazol-3-ylthiomethyl)-3-tert-butoxycarbonyl-7-chloro-2,3,4,5-tetrahydro-1H-benzo[d]azepine수율 43%

시약·촉매·용매 1

HCID 887Methanol용매2회

반응 조건

온도
0 °C

실험 절차

To a solution of 3-tert-butoxycarbonyl-6-carbamimidoylthiomethyl-7-chloro-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride (0.510 g, 1.256 mmol) in methanol (12.5 mL) at room temperature add solid sodium methoxide (0.14 g, 2.5 mmol) and then KSCN (0.12 g, 1.3 mmol). After cooling the reaction mixture to 0° C., add a solution of bromine (0.20 g, 1.3 mmol) in methanol (4 mL) dropwise. Stir the reaction mixture at room temperature overnight. Concentrate the reaction mixture in vacuo and partition the residue between DCM (100 mL) and water (50 mL). Extract the aqueous phase with DCM (50 mL). Dry the combined organic extracts over Na2SO4, filter and concentrate in vacuo. Dissolve the residue in DCM/methanol, add silica gel (5 g) and concentrate to a powder. Load the powder on to a dry column attached to a RediSep® column (40 g) and purify the crude mixture by preparative liquid chromatography (100:0 to 95:5 DCM/2M ammonia in methanol over 33 min; 95:5 to 80:20 DCM/2M ammonia in methanol over 33 min; 35 mL/min) to afford 6-(5-amino-[1,2,4]thiadiazol-3-ylthiomethyl)-3-tert-butoxycarbonyl-7-chloro-2,3,4,5-tetrahydro-1H-benzo[d]azepine (0.229 g, 43%). MS (ES+) m/z: 427.2 (M+H)+.

후처리

  1. concentrationConcentrate the reaction mixture in vacuo
  2. custompartition the residue between DCM (100 mL) and water (50 mL)
  3. extractionExtract the aqueous phase with DCM (50 mL)
  4. dry with materialDry the combined organic extracts over Na2SO4
  5. filtrationfilter
  6. concentrationconcentrate in vacuo
  7. dissolutionDissolve the residue in DCM/methanol
  8. additionadd silica gel (5 g)
  9. concentrationconcentrate to a powder
  10. custompurify the crude mixture by preparative liquid chromatography (100:0 to 95:5 DCM/2M ammonia in methanol over 33 min; 95:5 to 80:20 DCM/2M ammonia in methanol over 33 min; 35 mL/min)

출처 및 근거

ORD 기록
ord-32572d1cd6f04582b00b2cb8acbc2c23
출처 데이터셋
uspto-grants-2011_08
특허 번호
US07994163B2

반응 노트

불러오는 중…